OUR RESEARCH COMMITTEE
Research activity at Cure Cancer is guided by the Research Committee headed by a member of the board of directors who is also a practicing clinician.
Professor Clare Scott MBBS PhD FRACP (Chair)
Joint Division Head, Walter and Eliza Hall Institute of Medical Research
Medical Oncologist, Peter MacCallum Cancer Centre and Royal Melbourne Hospital
Professor Roger Reddel BSc (Med) MBBS PhD FRACP FAA
Director, Children's Medical Research Institute (CMRI)
Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney
Head, Cancer Research Unit, CMRI
Director, CellBank Australia
Co-director, ACRF International Centre for the Proteome of Human Cancer (ProCan).
Professor Michael Brown MBBS FRCPA FRACP PhD
Director, Cancer Clinical Trials Unit, and Senior Consultant Medical Oncologist, Department of Medical Oncology, Royal Adelaide Hospital Cancer Centre
Clinical Professor and Professor of Medical Oncology, School of Medicine, The University of Adelaide
Head, Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide
Dr Nic Waddell BSc (Hons) PhD
Group Leader (SRF-B): Medical Genomics QIMR Berghofer
Deputy co-ordinator of the Genetics and Computational Biology Department QIMR Berghofer
The task of the committee is to:
Provide expertise and administrative support underpinning the identification of suitable researchers for Cure Cancer grants, within the researcher space approved by the Board (currently Early Career researchers).
Design the optimum granting structures to meet the aims of Cure Cancer.
Optimize the funding environment for Cure Cancer grants via interactions with major national funding bodies (NHMRC, CA, CC) and with more specialized funding bodies (LFA, NBCF, PCFA, CCNSW, Cure Brain Cancer Foundation, Bowel Cancer Australia, Rare Cancers Australia) in order to leverage Cure Cancerfunding.
Advocate on behalf of Cure Cancer in the sector with a view to profile-raising of Cure Cancerand in particular to increase the quantity and quality of grant applicants.
Assist with Cure Cancer becoming the leading funder of early career grants (including via co-funding arrangements) and to be known nationally as such.
Provide scientific advice to Cure Cancer and to the Board as required.
Design the subsequent year's grant round, given that year's context.
Interact with our stakeholders: potential applicants, current grant holders, Cure Cancer alumni, leading scientific research institutes, which receive CCAF funding for their researchers, increasing awareness of Cure Cancer.
Provide advice to the Board about scientific risk.
Assess alternative funding opportunities for Cure Cancer, outside the core grant application process, as required, together with the Board.